May 31, 2022
The US Food and Drug Administration has cleared Abbot’s Freestyle Libre 3 system for use by people with diabetes aged 4 years and older. The new […]
May 31, 2022
The US Food and Drug Administration (FDA) has approved a label extension for oral risdiplam (Evrysdi, Genentech) to include presymptomatic infants younger than 2 months old […]
May 30, 2022
Immunotherapy with nivolumab (Opdivo) is now approved in the United States for first-line use in the treatment of unresectable advanced or metastatic esophageal squamous cell carcinoma […]
May 24, 2022
The Food and Drug Administration has approved tapinarof cream, 1%, a steroid-free topical cream applied once a day, for the treatment of mild, moderate, or severe […]
May 20, 2022
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib, a Janus kinase (JAK) inhibitor, for the treatment […]
May 13, 2022
The “Twincretin” era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration’s approval of tirzepatide for this indication on […]
May 13, 2022
The “Twincretin” era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration’s (FDA’s) approval of tirzepatide for this indication […]
May 13, 2022
Calling the death of 75-year-old patient Charlene Murphey a “terrible, terrible mistake,” a Tennessee judge sentenced former nurse RaDonda Vaught, RN, to 3 years of supervised […]
May 13, 2022
The US Food and Drug Administration (FDA) has approved the Onyx Frontier drug-eluting stent (DES) to treat patients with coronary artery disease, the device manufacturer, Medtronic, […]